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Editorial

The Burden of Mental Health Conditions in Children
With CKD
Katherine L. Kurzinski and Darcy K. Weidemann

A

s medical advancements for children with chronic
kidney disease (CKD) have led to improved long-term
survival, appropriate recognition and treatment of the
associated neuropsychiatric complications of CKD have
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become increasingly important. Recent studies examining
the national trends of mental health disorders in children,
particularly major depressive episodes and anxiety,
confirm significant increases in the prevalence of these
conditions in the general population.1 Limited studies have
shown a higher prevalence of psychiatric diagnoses in
children with CKD, highlighting the importance of
screening and characterization of mental health conditions
in this patient group. A recent cross-sectional study of the
Chronic Kidney Diseases in Children (CKiD) study by Stahl
et al2 in this issue of Kidney Medicine compared the prevalence of depression, anxiety, and attention-deficit/
hyperactivity disorder (ADHD) in children across all
stages of nondialysis CKD with that in children from the
general population. The authors also evaluated the performance of a validated self-reported depression screening
tool in comparison with parent-reported diagnoses, with
some unexpected results.2
In this study, investigators evaluated parent-reported
diagnoses of depression, anxiety, or ADHD obtained at
the study-entry interview from 875 children with CKD in
the CKiD cohort from 2005-2015. They also examined
comparable parent-reported diagnoses for the same 3
conditions from 72,699 individuals from the 2007 National Survey of Children’s Health (NSCH). Using loglinear regression with Poisson distribution analysis, data
were adjusted for age, sex, race, and ethnicity to provide
adjusted prevalence ratios (aPRs) for depression, anxiety,
and ADHD and ≥2 psychiatric diagnoses for children with
CKD compared with the general population. Unsurprisingly, children with CKD had a higher prevalence of
depression (crude prevalence, 5.7% vs 3.9%, respectively;
aPR, 1.32; 95% confidence interval [CI], 1.01-1.73),
while the adjusted prevalence of ADHD was similar between the CKiD and NSCH children (crude prevalence,
10.6% vs 9.2%, respectively; aPR, 1.03; 95% CI, 0.861.25). Perhaps the most unexpected finding of the study
was a substantially lower prevalence of anxiety in children
with CKD (crude prevalence, 4% vs 5.4% in the general
population; aPR, 0.72; 95% CI, 0.52-0.99). The prevalence of multiple psychiatric diagnoses was also lower in
children with CKD (crude prevalence, 3.1% vs 4.2% in the
general population; aPR, 0.68; 95% CI, 0.47-0.99).2
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The higher prevalence of depression in children with
CKD is not surprising and is supported by the existing
pediatric CKD literature, although the crude prevalence of
5.7% is lower than that observed in other studies, as
summarized in Table 1.2-9 Few prior studies included
comparisons to healthy children and adolescents. A largescale survey study showed a 12-month overall prevalence
of depression in general US adolescents of 11.3%,1 which
differs somewhat from what was identified in the NSCH
data, although differences in methodology may account
for this. The ascertainment of neuropsychiatric diagnoses
in the CKiD and NSCH study was quite similar, allowing
for an appropriate comparison while minimizing bias, and
represents a key strength of this study. This study’s findings did not vary by CKD stage, sex, race and ethnicity, or
maternal education status (although the aPR for depression
was higher in females). Other studies have been mixed,
with some showing no association of depression with the
estimated glomerular filtration rate or CKD stage or
severity and others demonstrating higher rates among
those with later-stage CKD, including children receiving
dialysis and after transplant.4-6,8 One discordant finding
within this study, however, was the lack of a correlation
between the depression prevalence and maternal education
level as noted in Kogon et al,8 as individuals who met the
Children’s Depression Inventory (CDI) criteria for
depression were more likely to have a mother with a high
school education or less.
Among adults with nondialysis CKD, 1 study demonstrated an overall prevalence of depression of 21%.10
Depressive symptoms are also described, with increased
incidences in children with other chronic diseases,
although the strength of this relationship varies by disease.11 The true impact of depression in children with CKD
remains unclear, but studies in children with kidney failure
have shown lower adherence to treatment regimens and
poorer health-related quality of life indices, while studies
in adults with CKD show increases in dialysis initiation,
hospitalization, and mortality.8,12 Given this potential
impact, it is imperative to screen for depressive symptoms
in children with CKD to allow for timely interventions.
Interestingly, anxiety was found to be 28% less prevalent
in children with CKD compared with the general pediatric
population. Similar unexpected findings were noted in a
smaller study by Kilicoglu et al13 that described significantly lower mean state anxiety scores, using a validated
anxiety inventory, in a cohort of 32 children receiving
dialysis or with a kidney transplant compared with healthy
controls. Also somewhat surprisingly, the authors noted a
relatively equal prevalence of ADHD between both groups,
1

2

Table 1. Summary of Existing Data Comparing Prevalence of Depression, Anxiety, ADHD in Nondialysis Pediatric CKD Versus Control Populations
Crude Prevalence
CKD (%)

Crude Prevalence
Control (%)

CKD, n
20

Control, n
28

Assessment
Depression Anxiety ADHD Depression Anxiety ADHD Tool
20
40
NA
4
14
NA
Birleson Scale
parent report

Bakr et al4
(2007)

19

NA

5.3

5.3

10.6

NA

NA

NA

SCICA DSM-IV

BerneyMartinet et al5
(2009)
Kogon et al6
(2013)

20

40

35a

35

5

15.2

12.1

7.5

K-SADS-PL

Dual center, age
12-18 (2003-2004)

44

NA

30

NA

NA

NA

NA

NA

CDI-2

Single center, age
2-18 CKD III-ESKD
(2011-2012)

Moreira et al7
(2015)
Kogon et al8
(2016)

28

28

14.3

57.1

NA

0

50

NA

CDI SCARED

344

NA

7b

NA

NA

NA

NA

NA

CDI

Single center, age
9-18 (2013)
CKiD, age 6-17
(2005-2008)

Kogon et al9
(2019)

71

64

12

NA

NA

8

NA

NA

CDI-2

NiCK, age 8-25

Stahl et al2
(2022)

875

72,699

5.7

4

10.6

3.9

5.4

9.2

CDI parent
report

CKiD, age 2-17
(2005-2015),
NSCH (2007)

Populations
Single center, age
3-18 (1983-1985,
1988-1989)
Single center, age
9-15 (2005-2006)

Other Findings
Evaluated ESKD,
transplant recipients
No correlation with
age, sex, CKD
duration, evaluated
ESKD
Evaluated transplant
recipients
Adjusted risk
depression lower for
duration (<3 y),
advanced CKD
Also evaluated Quality
of Life scores
CDI unrelated to
eGFR; depression
lower in maternal
education >HS
Evaluated in 2 dialysis
patients, depression
associated with
obesity
No correlation with
eGFR, sex, age,
maternal education, or
race and ethnicity

Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; CDI, Children’s Depression Inventory; CKD, chronic kidney disease; CKiD, Chronic Kidney Diseases in Children; DSM-KVIV, Diagnostic Statistical Manual of Mental
Disorders; eGFR, estimated glomerular ﬁltration rate; ESKD, end-stage kidney disease; HS, high school; K-SADS-PL, semistructured direct psychiatric interview; NA, not available; NiCK, Neurocognitive Assessment and
Magnetic Resonance Imaging Analysis of Children and Young Adults With CKD Study; NSCH, National Survey of Children’s Health; SCARED, Self-Report for Childhood Anxiety Related Disorders; SCICA, semistructured clinical
interview for children and adolescents.
a
Mood disorders, including major depression.
b
Added together depressive symptoms and treated patients.
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which is difficult to reconcile with the deficits in executive
functioning and attention observed in the neurocognitive
testing of even patients with mild CKD.14 Biologically
plausible mechanisms that provide a basis for increased
ADHD and other neurocognitive deficits in children with
CKD include low glomerular filtration rate affecting the
normal neural pathway development, hypertensive effects
on the developing brain, and attention variability noted in
those with higher levels of proteinuria.15,16
Factors underlying this perplexing association remain
unclear, although the authors postulate that the underreporting may be due to a variety of intentional and unintentional biases. Social desirability bias is plausible,
wherein parents who may share a close relationship with
their nephrology care team are less likely to report conditions perceived to be potential sources of stigmatization.
An alternate hypothesis postulates underreporting because
of state-wide differences in legislative protection for
mental health conditions. The selection bias of children
and families who agree to enroll in an intensive, longitudinal, prospective cohort study could also account for the
differences observed. As the study period of CKiD enrollment spanned 10 years from 2005-2015, and the NSCH
study was conducted in 2007, the possibility of a chronological bias because of changing prevalence rates of
neuropsychiatric diagnoses over time should also be
considered. The comparison of direct prevalence ratios
with such a difference in time spans when the prevalence
of these neuropsychiatric conditions is known to have
increased substantially over the past few decades may need
to be interpreted with caution. Finally, another interesting
theory that deserves further exploration in future studies is
the possibility that children with CKD are less likely to
receive standardized, formal psychosocial screenings for
these conditions because of delayed or absent preventative,
well-child care visits through their primary care providers.
A secondary analysis by Stahl et al2 examined pairwise
correlations with parent-reported depression diagnosis
data and clinically significant depressive symptoms on the
CDI assessment. The CDI is a self-reported, previously
validated assessment tool that is frequently used for the
assessment of pediatric depression.2,6,8,17 It has been
adapted for use by the CKiD study, with data collected
using this tool from 2005-2008 in children at least 6 years
of age.2,8,18 Surprisingly, parent-reported depression
diagnosis data were weakly correlated with the CDI for
clinically significant depression (r = 0.13; 95% CI, 0.030.23). The CDI identified clinically significant depression
in only 6 of 346 patients in whom the survey was
administered. In contrast, 24 of these patients had parentreported depression but were negative by CDI criteria.2
A definitive depression diagnosis requires a comprehensive assessment by a qualified mental health professional, although this is a resource-intensive process that
may not be feasible for large-scale epidemiological studies.
Access to qualified mental health providers even for
routine clinical care remains alarmingly poor. Although
Kidney Med Vol 4 | Iss 6 | June 2022 | 100478

the CDI screening tool has been validated for use in clinical
and nonclinical contexts for the identification of depression, 1 study showed poor performance and reduced
sensitivity of CDI for depression in a population of 112
children with chronic illness.19,20 Another, larger-scale
meta-analysis questioned the sensitivity of CDI for
depressive symptoms in chronic disease.11 Conversely,
parental awareness of mental health diagnoses may be
affected by significant recall bias, thereby limiting its use.
Further investigation into more accurate methods of
depression screening when a comprehensive assessment is
not feasible or validation studies of CDI in children with
CKD seems warranted before future utilization of this tool
because of the unacceptably low correlations observed in
this study. As recognized by the study authors, a balance
must be struck between efficient yet accurate psychiatric
assessments in this vulnerable population. The use of
longitudinal mental health assessments and the modification of existing study instruments to incorporate historical
symptom data seem like worthy future directions for the
research field.
Depression is more prevalent among children with
CKD, and its adverse effects on patient outcomes are well
described. Screening tools need to be optimized for
identification and referral for treatment in this population
to potentially improve CKD-related therapy adherence and
reduce overall morbidity, and possibly mortality. Further
evaluation of the true prevalence of anxiety and ADHD in
children with CKD is warranted given the conflicting results in the current literature. The pervasiveness and impacts of mental health disorders in children with CKD are
becoming more frequently recognized; thereby, formal,
standardized screening programs and timely interventions
should continue to be emphasized to provide optimal care
for this vulnerable population.
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